Perindopril: Clinical Trials

5 trials of Perindopril, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 2 completed. 5 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Unknown 3, Completed 2
Phase 21Unknown 1

Follow Perindopril: new trials by email Literature Review of Perindopril trials Research Report on Perindopril

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bioequivalence Study of Perindopril Tablets in Healthy Volunteers Under Fasting Conditions
Perindopril tablet, Prestarium® A tablet - Bioequivalence
Phase 1UnknownPharmtechnology LLC502024-01-092024-01-19
Bioequivalence Study of Perindopril /Amlodipine/Indapamide 8 mg (10 mg)/2.5 mg/10 mg Tablets in Healthy Volunteers Under Fasting Conditions
Perindopril/Indapamide/Amlodipine 8 mg/2.5 mg/10 mg tablet / Triplixam® 10 mg/2.5 mg/10 mg tablet - Bioequivalence
Phase 1UnknownPharmtechnology LLC502023-06-242023-07-11
DOXAZOSIN FOR PTSD
doxazosin, Perindopril, Placebo - PTSD
Phase 1CompletedBaylor College of Medicine302012-01-012022-04-26
Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research
perindopril OR bisoprolol OR placebo - Breast Cancer, Heart Failure
Phase 1 / Phase 2UnknownUniversity of Alberta992010-09-012016-02-09
An ACE Inhibitor (Perindopril) or an Angiotensin Receptor Blocker (Candesartan) as a Treatment for Methamphetamine Dependence
Perindopril, Placebo, Candesartan - Methamphetamine Dependence, Methamphetamine Abuse
Phase 1CompletedBaylor College of Medicine802009-05-012022-04-26

Conditions studied

Breast Neoplasms (1)  ·  Cardiotoxicity (1)  ·  Heart Failure (1)  ·  Stress Disorders, Post-Traumatic (1)  ·  Substance-Related Disorders (1)

Sponsors

Baylor College of Medicine (2)  ·  Pharmtechnology LLC (2)  ·  University of Alberta (1)

Countries

Russia (2)  ·  United States (2)  ·  Canada (1)

Top investigators

Ian Paterson, MD FRCPC (1)  ·  Irina Rodyukova (1)  ·  Thomas F Newton, M.D. (1)

Results publications

PMID 21794114, PMID 27249080

NIH funding

R01DA023468 (1)